Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
06 10 2022
Historique:
received: 30 07 2021
revised: 11 01 2022
pubmed: 19 1 2022
medline: 12 10 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

We evaluated flow-cytometric and transcriptome features of peripheral blood immune cells from early-phase (disease duration <5 years) SSc in comparison with late-phase SSc. Fifty Japanese patients with SSc (12 early SSc cases and 38 late SSc cases) and 50 age- and sex-matched healthy controls were enrolled. A comparison of flow-cytometric subset proportions and RNA-sequencing of 24 peripheral blood immune cell subsets was performed. We evaluated differentially expressed genes (DEGs), characterized the co-expressed gene modules, and estimated the composition of subpopulations by deconvolution based on single-cell RNA-sequencing data. As a disease control, idiopathic inflammatory myositis (IIM) patients were also evaluated. Analysing the data from early and late SSc, fraction II effector regulatory T cell (Fr. II eTreg) genes showed a remarkable differential gene expression, enriched for genes related to oxidative phosphorylation. Although the flow-cytometric proportion of Fr. II eTregs was not changed in early SSc, deconvolution indicated expansion of the activated subpopulation. Co-expressed gene modules of Fr. II eTregs demonstrated enrichment of the DEGs of early SSc and correlation with the proportion of the activated subpopulation. These results suggested that DEGs in Fr. II eTregs from patients with early SSc were closely associated with the increased proportion of the activated subpopulation. Similar dysregulation of Fr. II eTregs was also observed in data from patients with early IIM. RNA-seq of immune cells indicated the dysregulation of Fr. II eTregs in early SSc with increased proportion of the activated subpopulation.

Identifiants

pubmed: 35040949
pii: 6510927
doi: 10.1093/rheumatology/keac031
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4163-4174

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Satomi Kobayashi (S)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.
Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital.

Yasuo Nagafuchi (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.
Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo.

Mai Okubo (M)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Yusuke Sugimori (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Hiroaki Hatano (H)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Saeko Yamada (S)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Masahiro Nakano (M)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Ryochi Yoshida (R)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Yusuke Takeshima (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Mineto Ota (M)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.
Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo.

Yumi Tsuchida (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Yukiko Iwasaki (Y)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Keigo Setoguchi (K)

Department of Rheumatology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo.

Kanae Kubo (K)

Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital.

Tomohisa Okamura (T)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.
Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo.

Kazuhiko Yamamoto (K)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.
Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Kanagawa, Yokohama, Japan.

Hirofumi Shoda (H)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Keishi Fujio (K)

Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH